Molecular master switch for pancreatic cancer identified, potential predictor of treatment outcome




A recently described master regulator protein may explain the development of aberrant cell growth in the pancreas spurred by inflammation. The team profiled gene expression of mouse pancreatic ductal and duct-like cells from different states -- embryonic development, acute pancreatitis and K-ras mutation-driven carcinogenesis -- to find the molecular regulation of these processes.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/v...

Martes, 12 de Febrero 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección